The appearance of psoriasis can vary depending on the color of the skin. Representation of psoriasis on dark skin is often lacking in medical literature. Although psoriasis may have a distinct ...

At least twice as many patients on the approved spesolimab dose maintain improvement in skin symptoms and quality of life ...

These ingredients are ideal for inflammatory skin conditions like eczema and psoriasis because they can help relieve itchiness, dryness and scaling on the skin. To strengthen your skin barrier ...

Background: Psoriasis is a chronic inflammatory skin disease with a genetic predisposition and autoimmune component, often treated with immunomodulators such as biologic therapies. Objectives: In this ...

You may face a higher risk of developing a Candida fungus infection if you have psoriasis. This can make your psoriasis symptoms worse. It can also lead to other health issues, such as thrush or ...

Whether you suffer from psoriasis yourself or have heard about it from a famous Kardashian who has been very transparent about her symptoms, you know that the skin condition is far from glamorous and ...

Topical treatments, such as ointments and creams, are often the first-line treatment for people with psoriasis, according to the National Psoriasis Foundation (NPF). As psoriasis progresses or ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. By week 8, patients treated with roflumilast saw ...

In the long-running feud between Regeneron and Amgen around the companies’ competing PCSK9 cholesterol meds, Regeneron has eked out another legal win over its rival. A federal jury in Delaware ...

Additionally, some infections may exacerbate or trigger psoriasis, such as strep throat. Regardless of whether you are on a biologic or immunosuppressive medication for psoriasis, it’s essential ...

Icotrokinra showed rapid efficacy among adults and adolescents with at least moderate psoriasis. Most participants with scalp psoriasis treated with icotrokinra achieved the study’s primary ...

Psoriasis is a chronic inflammatory disorder for which phosphodiesterase-4 (PDE4) inhibitors have emerged as promising therapeutic agents due to an ability to regulate inflammatory signaling pathways.